China Everbright Limited to host Investment Conference 2016 in Qingdao: "Exploring the New Era of Alternative Asset Management"
HONG KONG, Sep 27, 2016 - (ACN Newswire) - The Everbright Investment Conference 2016, organised by the China Everbright Group's largest overseas financial investment flagship, China Everbright Limited ("CEL", stock code: 165.HK), will be held on 19 - 21 October 2016 at the Shangri-La Hotel, Qingdao.
Entering its fifth year following previous successes in Sanya, Xiamen, Shanghai and Chongqing, the Everbright Investment Conference is one of the most influential summits and platforms for the asset management industry. With more than 1,000 institutional investors and senior executives participating in the previous four conferences, it has become an important event where investment heavyweights gather to analyse economic and investment environments, share new trends and market developments, and identify new opportunities for investment.
In the face of highly complex economic and financial conditions, China is pushing for reforms in the financial market - speeding up the renminbi's internationalisation, accelerating the marketisation of interest rates and expanding capacity for developing innovative financial products. With banks, securities firms, trusts and funds jumping on the alternative asset allocation bandwagon, a new age of alternative asset management is dawning on the industry. In view of these new opportunities and challenges, the theme of this year's conference will be "From Insight to Foresight: A New Era of Alternative Asset Management", setting the stage for participants to explore alternative asset allocation with a new vision and from a fresh perspective.
A number of top investors, business leaders, experts and academics have been invited to attend this year's conference and speak at the event. Mr Chen Shuang, Executive Director and Chief Executive Officer of CEL, will deliver the opening speech, during which he will also provide an update on the latest developments at CEL. Also in attendance will be Mr Guan Tao, Senior Fellow and Member of the Academic Committee of the China Finance 40 Forum and the former Director-General of the Department of Balance of Payments at the State Administration of Foreign Exchange, Mr Hugo Shong, Founding General Partner of IDG Capital Partners, and Mr Liu Jun, Deputy General Manager of China Everbright Group Limited, Deputy Chairman of CEL's Board of Directors, who will draw from their years of research and hands-on experience in finance to focus on how cross-border investment can drive the growth of Chinese enterprises. They will also share their unique insights on current and future economic and investment prospects.
At the panel discussion session, industry leaders will discuss the vitality of the 'Industry + Finance' investment model in China and new investment opportunities in the current environment. They include Mr Thomas Deng, Managing Director, Regional Chief Investment Officer for Greater China and Chief China Strategist in Chief Investment Office of UBS Wealth Management; Mr Jason Jiang, Founder and Chairman of Focus Media; Mr Frank Tang, Chief Executive Officer and Managing Partner of FountainVest Partners; and Mr Zhang Mingao, General Manager of Asset Management Department of China Everbright Bank.
For more details about the Everbright Investment Conference 2016, please visit: www.everbright-conference2016.com
About China Everbright Limited
China Everbright Limited ("CEL", stock code: 165.HK), established in Hong Kong in 1997, persistently pursues its "Macro Asset Management" strategy with specific focuses on cross-border asset management and investment businesses. CEL manages a portfolio of private equity funds, venture capital funds, sector focus funds, mezzanine funds, hedge funds and principal investment funds, all operated via an international management platform, and provides overseas investors with opportunities to explore and invest in companies with fast growth potential in mainland China. CEL also seeks investment opportunities from overseas and provides diversified financial services for its clients on the mainland. China Everbright Limited, a member of China Everbright Group, is the second-largest shareholder of Everbright Securities (stock code: 601788.SH, 6178.HK), a strategic shareholder of China Everbright Bank (stock code: 601818.SH, 6818.HK), the single largest shareholder of the Hong Kong-listed China Aircraft Leasing Group Holdings Limited (stock code: 1848.HK) , the largest shareholder of Shanghai Jiabao Industry & Commerce (Group) Co., Ltd (stock code: 600622.SH) and the second-largest shareholder of the Singapore-listed Ying Li International Real Estate Limited (stock code: 5DM. SGX).
After the launch of "Shanghai-Hong Kong Stock Connect" on 10 April 2014, CEL became one of the first batch of specific stocks listed on The Stock Exchange of Hong Kong that can be directly traded by Mainland investors.
By practising its philosophy of "Making Wealth Simple", CEL leverages its own substantial financial strength as well as the position and influence of China Everbright Group and its affiliated companies in the financial industry in China. As a result, the Group has successfully built huge cross-border social and business networks in Hong Kong and the Mainland, and established a reputable image in the market.
For more information about CEL, please visit www.everbright165.com.
For enquiries, please contact: Golin Jackie Cheung Tel: +852 2501 7901 Email: jcheung@golin.com
Max Lau Tel: +852 2501 7905 Email: mlau@golin.com
Source: China Everbright Ltd Sectors: Daily Finance, Funds & Equities
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Hong Kong Watch & Clock Fair, Salon de TIME return in September Aug 30, 2025 02:50 JST
|  Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building Aug 29, 2025 18:54 JST
|  Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma Aug 29, 2025 18:17 JST
|  Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage Aug 29, 2025 15:17 JST
|  SenseTime Announces 2025 Interim Results Aug 28, 2025 21:20 JST
|  Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth Aug 28, 2025 19:09 JST
|  Baguio Green Group (1397.HK) Announces 2025 Interim Results Aug 28, 2025 19:03 JST
|  Production, Sales and Export Results for July, 2025 Aug 28, 2025 17:36 JST
|  Sales, Production, and Export Results for July 2025 Aug 28, 2025 17:25 JST
|  The University of Tokyo and DENSO Jointly Establish a Social Cooperation Program: "Building Sustainable Production System Infrastructure with Advanced AI Technology" Aug 28, 2025 16:33 JST
|  Overview of Honda Exhibits at the Japan Mobility Show 2025 Aug 28, 2025 15:49 JST
|  NEC develops AI technology for digitalizing work tasks without the need for pre-training and utilizing video from multiple cameras covering wide area worksites Aug 27, 2025 22:57 JST
|  Result of the Business Plan Review for the Offshore Wind Power Generation Projects in Japan Aug 27, 2025 22:27 JST
|  Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision Aug 27, 2025 21:50 JST
|  MHI Becomes First Japanese Company to Acquire ISO 19443:2018 Certification in the Nuclear Energy Field Aug 27, 2025 21:32 JST
|  Mitsubishi Logisnext to Demonstrate Automated Forklift Equipped with "SynfoX" at "4th INNOVATION EXPO" Aug 27, 2025 20:59 JST
|  TANAKA to Showcase Advanced Semiconductor Materials in its Inaugural Participation at SEMICON India 2025 Aug 26, 2025 13:30 JST
|  Honda to Hold Official e-Motorsports Event, "Honda Racing eMS 2025" Aug 26, 2025 13:17 JST
|  Mitsubishi Corporation Invests in Fullerton Health Aug 26, 2025 12:54 JST
|  Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab) Aug 25, 2025 19:30 JST
|
More Latest Release >>
|